Opti Brain
Opti Brain, licence 80080001: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Supplements K.D. Inc.
- NPN or DIN-HM
- 80080001
- Status
- Active licence
- Licence date
- 12 September 2017
- Revision date
- 26 October 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 0.3 Grammes | Not calculated |
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 0.3 Grammes | Not calculated |
| Bacopa monnieri Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 750 milligramme Potency : 45.0 % Bacosides A et B | 75.0 milligramme | Not calculated |
| Phosphatidyl sérine Source : Lécithine de soja enrichie en phosphatidylsérine | 50.0 milligramme | Not calculated |
| Niacinamide Source : Niacinamide | 33.0 milligramme | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 12.5 milligramme | 50,000 µg |
| Vitamine B12 Source : Méthylcobalamine | 100.0 microgrammes | Not calculated |
| Folate Source : L-5-methyltetrahydrofolate | 50.0 microgrammes | Not calculated |
Non-medicinal ingredients
L-Leucine, Hydroxypropylméthylcellulose, Poudre d'Oryza Sativa (Riz), Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Aide à soutenir la santé cognitive et/ou les fonctions cérébrales. Source de vitamines qui contribuent au maintien d'une bonne santé. Source de vitamines qui contribuent à la croissance et au développement normaux. Aide au métabolisme de l'énergie et à la formation des tissus. Aide à maintenir les capacités du corps à métaboliser les nutriments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si vous êtes enceinte ou si vous allaitez, consulter un praticien de soins de santé avant d'en faire l'usage. Si vous souffrez d'une maladie du foie ou des reins et/ou un trouble épileptique, consulter un praticien de soins de santé avant d'en faire l'usage.
- Effets indésirables connus
Peut causer des problèmes digestifs.
Source
Official Health Canada record, licence 80080001
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.